Fact and fiction in tuberculosis vaccine research: 10 years later, The Lancet Infectious Diseases, vol.11, issue.8, pp.633-640, 2011. ,
DOI : 10.1016/S1473-3099(11)70146-3
Global Incidence of Multidrug???Resistant Tuberculosis, The Journal of Infectious Diseases, vol.194, issue.4, pp.479-485, 2006. ,
DOI : 10.1086/505877
Availability of anti-tuberculosis drugs in Europe: Table 1???, European Respiratory Journal, vol.40, issue.2, pp.500-503, 2012. ,
DOI : 10.1183/09031936.00009212
HIV Infection???Associated Tuberculosis: The Epidemiology and the Response, Clinical Infectious Diseases, vol.50, issue.s3, pp.201-207, 2010. ,
DOI : 10.1086/651492
The granulomatous inflammatory response. A review, Am J Pathol, vol.84, pp.164-192, 1976. ,
Granulomas in schistosome and mycobacterial infections: a model of local immune responses, Trends in Immunology, vol.24, issue.1, pp.44-52, 2003. ,
DOI : 10.1016/S1471-4906(02)00006-6
An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells, Cellular Microbiology, vol.16, issue.5, pp.423-433, 2004. ,
DOI : 10.1046/j.1365-2567.1999.00877.x
Temporal and Spatial Arrangement of Lymphocytes within Lung Granulomas Induced by Aerosol Infection with Mycobacterium tuberculosis, Infection and Immunity, vol.69, issue.3, pp.1722-1728, 2001. ,
DOI : 10.1128/IAI.69.3.1722-1728.2001
-induced human granulomas cannot mediate mycobacterial uptake, The Journal of Pathology, vol.9, issue.1, pp.76-85, 2007. ,
DOI : 10.1002/path.2092
URL : https://hal.archives-ouvertes.fr/hal-01258471
Foamy macrophages and the progression of the human tuberculosis granuloma, Nature Immunology, vol.65, issue.9, pp.943-948, 2009. ,
DOI : 10.1038/ni.1758
High Content Screening Identifies Decaprenyl-Phosphoribose 2??? Epimerase as a Target for Intracellular Antimycobacterial Inhibitors, PLoS Pathogens, vol.149, issue.10, p.1000645, 2009. ,
DOI : 10.1371/journal.ppat.1000645.s010
model for tuberculosis drug discovery, Future Medicinal Chemistry, vol.2, issue.8, pp.1283-1293, 2010. ,
DOI : 10.4155/fmc.10.223
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis, Nature Medicine, vol.47, issue.9, pp.1157-1160, 2013. ,
DOI : 10.1006/abio.1997.2145
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency, Science, vol.280, issue.5368, pp.1432-1435, 1998. ,
DOI : 10.1126/science.280.5368.1432
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis, New England Journal of Medicine, vol.367, issue.16, pp.1508-1518, 2012. ,
DOI : 10.1056/NEJMoa1201964
Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6???,7???-Dihydrospiro[Piperidine-4,4???-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3, PLoS ONE, vol.1, issue.8, p.60933, 2013. ,
DOI : 10.1371/journal.pone.0060933.s004
The curious characteristics of pyrazinamide: a review, Int J Tuberc Lung Dis, vol.7, pp.6-21, 2003. ,
?, American Review of Respiratory Disease, vol.141, issue.1, pp.250-252, 1990. ,
DOI : 10.1164/ajrccm/141.1.250
Pyrazinamide is not effective against intracellularly growing Mycobacterium tuberculosis., Antimicrobial Agents and Chemotherapy, vol.32, issue.2, p.287, 1988. ,
DOI : 10.1128/AAC.32.2.287
Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured humanmonocyte-derived macrophages, Int J Tuberc Lung Dis, vol.4, pp.491-495, 2000. ,
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial, The Lancet, vol.380, issue.9846, pp.986-993, 2012. ,
DOI : 10.1016/S0140-6736(12)61080-0
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis, New England Journal of Medicine, vol.360, issue.23, pp.2397-2405, 2009. ,
DOI : 10.1056/NEJMoa0808427
An In Vitro Model of Mycobacterial Granuloma to Investigate the Immune Response in Brain-Injured Patients*, Critical Care Medicine, vol.41, issue.1, pp.245-254, 2013. ,
DOI : 10.1097/CCM.0b013e3182676052